The effects of simvastatin and fenofibrate on malondialdehyde and reduced glutathione concentrations in the plasma, liver, and brain of normolipidaemic and hyperlipidaemic rats

1. Parums DV. Editorial: The 2021 European Society of Cardiology (ESC) guidelines on the real-world prevention of atherosclerotic cardiovascular disease (ASCVD). Med Sci Monit 2021;27:e9351721–3. doi: 10.12659/MSM.935172 Parums DV . Editorial: The 2021 European Society of Cardiology (ESC) guidelines on the real-world prevention of atherosclerotic cardiovascular disease (ASCVD) . Med Sci Monit 2021 ; 27 : e9351721 – 3 . doi: 10.12659/MSM.935172 Open DOISearch in Google Scholar

2. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, Michos ED, Miedema MD, Muñoz D, Smith SC Jr, Virani SS, Williams KA Sr, Yeboah J, Ziaeian B. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2019;140(11):e596-e646. doi: 10.1161/CIR.0000000000000678 Arnett DK Blumenthal RS Albert MA Buroker AB Goldberger ZD Hahn EJ Himmelfarb CD Khera A Lloyd-Jones D McEvoy JW Michos ED Miedema MD Muñoz D Smith SC Jr Virani SS Williams KA Sr Yeboah J Ziaeian B . 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines . Circulation 2019 ; 140 ( 11 ): e596 - e646 . doi: 10.1161/CIR.0000000000000678 Open DOISearch in Google Scholar

3. Bedi O, Dhawan V, Sharma PL, Kumar P. Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol 2016;389:695–712. doi: 10.1007/s00210-016-1252-4 Bedi O Dhawan V Sharma PL Kumar P . Pleiotropic effects of statins: new therapeutic targets in drug design . Naunyn Schmiedebergs Arch Pharmacol 2016 ; 389 : 695 – 712 . doi: 10.1007/s00210-016-1252-4 Open DOISearch in Google Scholar

4. Botta M, Audano M, Sahebkar A, Sirtori CR, Mitro N, Ruscica M. PPAR agonists and metabolic syndrome: an established role? Int J Mol Sci 2018;19(4):1197. doi: 10.3390/ijms19041197 Botta M Audano M Sahebkar A Sirtori CR Mitro N Ruscica M . PPAR agonists and metabolic syndrome: an established role? Int J Mol Sci 2018 ; 19 ( 4 ): 1197 . doi: 10.3390/ijms19041197 Open DOISearch in Google Scholar

5. Ali FY, Armstrong PC, Dhanji AR, Tucker AT, Paul-Clark MJ, Mitchell JA, Warner TD. Antiplatelet actions of statins and fibrates are mediated by PPARs. Arterioscler Thromb Vasc Biol 2009;29:706–11. doi: 10.1161/ATVBAHA.108.183160 Ali FY Armstrong PC Dhanji AR Tucker AT Paul-Clark MJ Mitchell JA Warner TD . Antiplatelet actions of statins and fibrates are mediated by PPARs . Arterioscler Thromb Vasc Biol 2009 ; 29 : 706 – 11 . doi: 10.1161/ATVBAHA.108.183160 Open DOISearch in Google Scholar

6. Sahebkar A, Serban MC, Mikhailidis DP, Toth PP, Muntner P, Ursoniu S, Mosterou S, Glasser S, Martin SS, Jones SR, Rizzo M, Rysz J, Sniderman AD, Pencina MJ, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis. Pharmacol Res 2016;103:236–52. doi: 10.1016/j.phrs.2015.12.001 Sahebkar A Serban MC Mikhailidis DP Toth PP Muntner P Ursoniu S Mosterou S Glasser S Martin SS Jones SR Rizzo M Rysz J Sniderman AD Pencina MJ Banach M Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group . Head-to-head comparison of statins versus fibrates in reducing plasma fibrinogen concentrations: A systematic review and meta-analysis . Pharmacol Res 2016 ; 103 : 236 – 52 . doi: 10.1016/j.phrs.2015.12.001 Open DOISearch in Google Scholar

7. Navarese EP, Buffon A, Andreotti F, Kozinski M, Welton N, Fabiszak T, Caputo S, Grzesk G, Kubica A, Swiatkiewicz I, Sukiennik A, Kelm M, De Servi S, Kubica J. Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 2013;111:1123–30. doi: 10.1016/j.amjcard.2012.12.037 Navarese EP Buffon A Andreotti F Kozinski M Welton N Fabiszak T Caputo S Grzesk G Kubica A Swiatkiewicz I Sukiennik A Kelm M De Servi S Kubica J . Meta-analysis of impact of different types and doses of statins on new-onset diabetes mellitus . Am J Cardiol 2013 ; 111 : 1123 – 30 . doi: 10.1016/j.amjcard.2012.12.037 Open DOISearch in Google Scholar

8. Okuyama H, Langsjoen PH, Hamazaki T, Ogushi Y, Hama R, Kobayashi T, Uchino H. Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms. Expert Rev Clin Pharmacol 2015;8:189–99. doi: 10.1586/17512433.2015.1011125 Okuyama H Langsjoen PH Hamazaki T Ogushi Y Hama R Kobayashi T Uchino H . Statins stimulate atherosclerosis and heart failure: pharmacological mechanisms . Expert Rev Clin Pharmacol 2015 ; 8 : 189 – 99 . doi: 10.1586/17512433.2015.1011125 Open DOISearch in Google Scholar

9. Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart JC. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998;98:2088–93. doi: 10.1161/01.cir.98.19.2088 Staels B Dallongeville J Auwerx J Schoonjans K Leitersdorf E Fruchart JC . Mechanism of action of fibrates on lipid and lipoprotein metabolism . Circulation 1998 ; 98 : 2088 – 93 . doi: 10.1161/01.cir.98.19.2088 Open DOISearch in Google Scholar

10. Martin G, Duez H, Blanquart C, Berezowski V, Poulain P, Fruchart JC, Najib-Fruchart J, Glineur C, Staels B. Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I. J Clin Invest 2001;107:1423–32. doi: 10.1172/JCI10852 Martin G Duez H Blanquart C Berezowski V Poulain P Fruchart JC Najib-Fruchart J Glineur C Staels B . Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-I . J Clin Invest 2001 ; 107 : 1423 – 32 . doi: 10.1172/JCI10852 Open DOISearch in Google Scholar

11. Wójtowicz S, Strosznajder AK, Jeżyna M, Strosznajder JB. The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer’s disease and other neurodegenerative disorders. Neurochem Res 2020;45:972–88. doi: 10.1007/s11064-020-02993-5 Wójtowicz S Strosznajder AK Jeżyna M Strosznajder JB . The novel role of PPAR alpha in the brain: promising target in therapy of Alzheimer’s disease and other neurodegenerative disorders . Neurochem Res 2020 ; 45 : 972 – 88 . doi: 10.1007/s11064-020-02993-5 Open DOISearch in Google Scholar

12. Hong K-S, Lee JS. Statins in acute ischemic stroke: a systematic review. J Stroke 2015;17:282–301. doi: 10.5853/jos.2015.17.3.282 Hong K-S Lee JS . Statins in acute ischemic stroke: a systematic review . J Stroke 2015 ; 17 : 282 – 301 . doi: 10.5853/jos.2015.17.3.282 Open DOISearch in Google Scholar

13. Chataway J, Schuerer N, Alsanousi A, Chan D, MacManus D, Hunter K, Anderson V, Bangham CR, Clegg S, Nielsen C, Fox NC, Wilkie D, Nicholas JM, Calder VL, Greenwood J, Frost C, Nicholas R. Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial. Lancet 2014;383:2213–21. doi: 10.1016/S0140-6736(13)62242-4 Chataway J Schuerer N Alsanousi A Chan D MacManus D Hunter K Anderson V Bangham CR Clegg S Nielsen C Fox NC Wilkie D Nicholas JM Calder VL Greenwood J Frost C Nicholas R . Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial . Lancet 2014 ; 383 : 2213 – 21 . doi: 10.1016/S0140-6736(13)62242-4 Open DOISearch in Google Scholar

14. Lee Y-C, Lin C-H, Wu R-M, Lin M-S, Lin J-W, Chang C-H, Lai M-S. Discontinuation of statin therapy associates with Parkinson disease: a population-based study. Neurology 2013;81:410–6. doi: 10.1212/WNL.0b013e31829d873c Lee Y-C Lin C-H Wu R-M Lin M-S Lin J-W Chang C-H Lai M-S . Discontinuation of statin therapy associates with Parkinson disease: a population-based study . Neurology 2013 ; 81 : 410 – 6 . doi: 10.1212/WNL.0b013e31829d873c Open DOISearch in Google Scholar

15. Shinohara M, Sato N, Shimamura M, Kurinami H, Hamasaki T, Chatterjee A, Rakugi H, Morishita R. Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors. Front Aging Neurosci 2014;6:71. doi: 10.3389/fnagi.2014.00071 Shinohara M Sato N Shimamura M Kurinami H Hamasaki T Chatterjee A Rakugi H Morishita R . Possible modification of Alzheimer’s disease by statins in midlife: interactions with genetic and non-genetic risk factors . Front Aging Neurosci 2014 ; 6 : 71 . doi: 10.3389/fnagi.2014.00071 Open DOISearch in Google Scholar

16. Losey P, Ladds E, Laprais M, Guevel B, Burns L, Bordet R, Anthony DC. The role of PPAR activation during the systemic response to brain injury. J Neuroinflammation 2015;12:99. doi: 10.1186/s12974-015-0295-7 Losey P Ladds E Laprais M Guevel B Burns L Bordet R Anthony DC . The role of PPAR activation during the systemic response to brain injury . J Neuroinflammation 2015 ; 12 : 99 . doi: 10.1186/s12974-015-0295-7 Open DOISearch in Google Scholar

17. Chen XR, Besson VC, Beziaud T, Plotkine M, Marchand-Leroux C. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury. J Pharmacol Exp Ther 2008;326:966–74. doi: 10.1124/jpet.108.140368 Chen XR Besson VC Beziaud T Plotkine M Marchand-Leroux C . Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury . J Pharmacol Exp Ther 2008 ; 326 : 966 – 74 . doi: 10.1124/jpet.108.140368 Open DOISearch in Google Scholar

18. Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D Knight AR, Taylor EL, Oettrich J, Ruskovska T, Gasparovic AC, Cuadrado A, Weber D, Poulsen HE, Grune T, Schmidt HH, Ghezzi P. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal 2015;23:1144–70. doi: 10.1089/ars.2015.6317 Frijhoff J Winyard PG Zarkovic N Davies SS Stocker R Cheng D Knight AR Taylor EL Oettrich J Ruskovska T Gasparovic AC Cuadrado A Weber D Poulsen HE Grune T Schmidt HH Ghezzi P . Clinical relevance of biomarkers of oxidative stress . Antioxid Redox Signal 2015 ; 23 : 1144 – 70 . doi: 10.1089/ars.2015.6317 Open DOISearch in Google Scholar

19. Aoyama K. Glutathione in the brain. Int J Mol Sci 2021;22(9):5010. doi: 10.3390/ijms22095010 Aoyama K . Glutathione in the brain . Int J Mol Sci 2021 ; 22 ( 9 ): 5010 . doi: 10.3390/ijms22095010 Open DOISearch in Google Scholar

20. Lu SC. Regulation of glutathione synthesis. Mol Aspects Med 2009;30:42–59. doi: 10.1016/j.mam.2008.05.005 Lu SC . Regulation of glutathione synthesis . Mol Aspects Med 2009 ; 30 : 42 – 59 . doi: 10.1016/j.mam.2008.05.005 Open DOISearch in Google Scholar

21. Macan M, Vukšić A, Žunec S, Konjevoda P, Lovrić J, Kelava M, Štambuk N, Vrkić N, Bradamante V. Effects of simvastatin on malondialdehyde level and esterase activity in plasma and tissue of normolipidaemic rats. Pharmacol Rep 2015;67:907–13. doi: 10.1016/j.pharep.2015.02.005 Macan M Vukšić A Žunec S Konjevoda P Lovrić J Kelava M Štambuk N Vrkić N Bradamante V . Effects of simvastatin on malondialdehyde level and esterase activity in plasma and tissue of normolipidaemic rats . Pharmacol Rep 2015 ; 67 : 907 – 13 . doi: 10.1016/j.pharep.2015.02.005 Open DOISearch in Google Scholar

22. Mohamadin AM, Elberry AA, Abdel Gawad HS, Morsy GM, Al-Abbasi FA. Protective effects of simvastatin, a lipid lowering agent, against oxidative damage in experimental diabetic rats. J Lipids 2011;2011:167958. doi: 10.1155/2011/167958 Mohamadin AM Elberry AA Abdel Gawad HS Morsy GM Al-Abbasi FA . Protective effects of simvastatin, a lipid lowering agent, against oxidative damage in experimental diabetic rats . J Lipids 2011 ; 2011 : 167958 . doi: 10.1155/2011/167958 Open DOISearch in Google Scholar

23. Zeng H, Liu Z. Atorvastatin induces hepatotoxicity in diabetic rats via oxidative stress, inflammation, and anti-apoptotic pathway. Med Sci Monit 2019;25:6165–73. doi: 10.12659/MSM.915790 Zeng H Liu Z . Atorvastatin induces hepatotoxicity in diabetic rats via oxidative stress, inflammation, and anti-apoptotic pathway . Med Sci Monit 2019 ; 25 : 6165 – 73 . doi: 10.12659/MSM.915790 Open DOISearch in Google Scholar

24. Bełtowski J, Wójcicka G, Mydlarczyk M, Jamroz A. The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity. J Physiol Pharmacol 2002;53:463–75. PMID: 12369742 Bełtowski J Wójcicka G Mydlarczyk M Jamroz A . The effect of peroxisome proliferator-activated receptors alpha (PPARalpha) agonist, fenofibrate, on lipid peroxidation, total antioxidant capacity, and plasma paraoxonase 1 (PON 1) activity . J Physiol Pharmacol 2002 ; 53 : 463 – 75 . PMID: 12369742 Search in Google Scholar

25. Macan M, Konjevoda P, Lovrić J, Koprivanac M, Kelava M, Vrkić N, Bradamante V. The influence of gemfibrozil on malondialdehyde level and paraoxonase 1 activity in Wistar and fisher rats. Basic Clin Pharmacol Toxicol 2011;108:428–35. doi: 10.1111/j.1742-7843.2011. 00674.x Macan M Konjevoda P Lovrić J Koprivanac M Kelava M Vrkić N Bradamante V . The influence of gemfibrozil on malondialdehyde level and paraoxonase 1 activity in Wistar and fisher rats . Basic Clin Pharmacol Toxicol 2011 ; 108 : 428 – 35 . doi: 10.1111/j.1742-7843.2011. 00674.x Open DOISearch in Google Scholar

26. Ciriolo MR, Mavelli I, Rotilio G, Borzatta V, Cristofari M, Stanzani L. Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidaemic drugs. FEBS Lett 1982;144:264–8. doi: 10.1016/0014-5793(82)80651-0 Ciriolo MR Mavelli I Rotilio G Borzatta V Cristofari M Stanzani L . Decrease of superoxide dismutase and glutathione peroxidase in liver of rats treated with hypolipidaemic drugs . FEBS Lett 1982 ; 144 : 264 – 8 . doi: 10.1016/0014-5793(82)80651-0 Open DOISearch in Google Scholar

27. Ciriolo MR, Rossi L, Mavelli I, Rotilio G, Borzatta V, Cristofori M, Barbanti M. The effects of hypolipidaemic agents derived from procetofenic acid on the activity of superoxide dismutase and glutathione peroxidase and on malonyl dialdehyde production of rat liver. Arzneimittelforschung 1984;34:465–7. PMID: 6540105 Ciriolo MR Rossi L Mavelli I Rotilio G Borzatta V Cristofori M Barbanti M . The effects of hypolipidaemic agents derived from procetofenic acid on the activity of superoxide dismutase and glutathione peroxidase and on malonyl dialdehyde production of rat liver . Arzneimittelforschung 1984 ; 34 : 465 – 7 . PMID: 6540105 Search in Google Scholar

28. Abdoli N, Heidari R, Azarmi Y, Eghbal MA. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol 2013;27:287–94. doi: 10.1002/jbt.21485 Abdoli N Heidari R Azarmi Y Eghbal MA . Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes . J Biochem Mol Toxicol 2013 ; 27 : 287 – 94 . doi: 10.1002/jbt.21485 Open DOISearch in Google Scholar

29. Eghbal MA, Abdoli N, Azarmi Y. Efficiency of hepatocyte pretreatment with coenzyme Q₁₀ against statin toxicity. Arh Hig Rada Toksikol 2014;65:101–8. doi: 10.2478/10004-1254-65-2014-2398 Eghbal MA Abdoli N Azarmi Y . Efficiency of hepatocyte pretreatment with coenzyme Q₁₀ against statin toxicity . Arh Hig Rada Toksikol 2014 ; 65 : 101 – 8 . doi: 10.2478/10004-1254-65-2014-2398 Open DOISearch in Google Scholar

30. Yaribeygi H, Mohammadi MT, Rezaee R, Sahebkar A. Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy. J Cell Biochem 2018;119:7458–69. doi: 10.1002/jcb.27055 Yaribeygi H Mohammadi MT Rezaee R Sahebkar A . Fenofibrate improves renal function by amelioration of NOX-4, IL-18, and p53 expression in an experimental model of diabetic nephropathy . J Cell Biochem 2018 ; 119 : 7458 – 69 . doi: 10.1002/jcb.27055 Open DOISearch in Google Scholar

31. Wood WG, Eckert GP, Igbavboa U, Müller WE. Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci 2010;1199:69–76. doi: 10.1111/j.1749-6632.2009.05359.x Wood WG Eckert GP Igbavboa U Müller WE . Statins and neuroprotection: a prescription to move the field forward . Ann N Y Acad Sci 2010 ; 1199 : 69 – 76 . doi: 10.1111/j.1749-6632.2009.05359.x Open DOISearch in Google Scholar

32. Deplanque D, Gelé P, Pétrault O, Six I, Furman C, Bouly M, Nion S, Dupuis B, Leys D, Fruchart JC, Cecchelli R, Staels B, Duriez P, Bordet R. Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment. J Neurosci 2003;23:6264–71. doi: 10.1523/JNEUROSCI.23-15-06264.2003 Deplanque D Gelé P Pétrault O Six I Furman C Bouly M Nion S Dupuis B Leys D Fruchart JC Cecchelli R Staels B Duriez P Bordet R . Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment . J Neurosci 2003 ; 23 : 6264 – 71 . doi: 10.1523/JNEUROSCI.23-15-06264.2003 Open DOISearch in Google Scholar

33. Balakumar P, Varatharajan R, Nyo YH, Renushia R, Raaginey D, Oh AN, Akhtar SS, Rupeshkumar M, Sundram K, Dhanaraj SA. Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats. Pharmacol Res 2014;90:36–47. doi: 10.1016/j.phrs.2014.08.008 Balakumar P Varatharajan R Nyo YH Renushia R Raaginey D Oh AN Akhtar SS Rupeshkumar M Sundram K Dhanaraj SA . Fenofibrate and dipyridamole treatments in low-doses either alone or in combination blunted the development of nephropathy in diabetic rats . Pharmacol Res 2014 ; 90 : 36 – 47 . doi: 10.1016/j.phrs.2014.08.008 Open DOISearch in Google Scholar

34. Fatani SH, Naderaralli EK, Panchiani S, Shah F, Wong C. The effects of dietary obesity on protein expressions of insulin signalling pathway in rat aorta. Drug Discov Ther 2008;2:256–61. PMID: 22504637 Fatani SH Naderaralli EK Panchiani S Shah F Wong C . The effects of dietary obesity on protein expressions of insulin signalling pathway in rat aorta . Drug Discov Ther 2008 ; 2 : 256 – 61 . PMID: 22504637 Search in Google Scholar

35. Nezić L, Skrbić R, Dobrić S, Stojiljković MP, Jaćević V, Stoisavljević Satara S, Milovanović ZA, Stojaković N. Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation. Basic Clin Pharmacol Toxicol 2009;104:185–91. doi: 10.1111/j.1742-7843.2008.00302.x Nezić L Skrbić R Dobrić S Stojiljković MP Jaćević V Stoisavljević Satara S Milovanović ZA Stojaković N . Simvastatin and indomethacin have similar anti-inflammatory activity in a rat model of acute local inflammation . Basic Clin Pharmacol Toxicol 2009 ; 104 : 185 – 91 . doi: 10.1111/j.1742-7843.2008.00302.x Open DOISearch in Google Scholar

36. Simsek Ozek N, Burak Bal I, Yildirim S, Rustu Inur, Severcan F. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles. Biochim Biophys Acta 2014;1840:406–14. doi: 10.1016/j.bbagen.2013.09.010 Simsek Ozek N Burak Bal I Yildirim S Rustu Inur Severcan F. Structural and functional characterization of simvastatin-induced myotoxicity in different skeletal muscles . Biochim Biophys Acta 2014 ; 1840 : 406 – 14 . doi: 10.1016/j.bbagen.2013.09.010 Open DOISearch in Google Scholar

37. Pravilnik o zaštiti životinja koje se koriste u znanstvene svrhe [Regulation of the protection of animals used for scientific purposes, in Croatian]. Narodne novine 55/2013. Pravilnik o zaštiti životinja koje se koriste u znanstvene svrhe [Regulation of the protection of animals used for scientific purposes, in Croatian] . Narodne novine 55 / 2013 . Search in Google Scholar

38. Guillen J. FELASA guidelines and recommendations. J Am Assoc Lab Anim Sci 2012;51:311–21. PMCID: PMC3358979 Guillen J . FELASA guidelines and recommendations . J Am Assoc Lab Anim Sci 2012 ; 51 : 311 – 21 . PMCID: PMC3358979 Search in Google Scholar

39. Drury JA, Nycyk JA, Cooke RW. Comparison of urinary and plasma malondialdehyde in preterm infants. Clin Chim Acta 1997;263:177–85. doi: 10.1016/s0009-8981(97)00051-x Drury JA Nycyk JA Cooke RW . Comparison of urinary and plasma malondialdehyde in preterm infants . Clin Chim Acta 1997 ; 263 : 177 – 85 . doi: 10.1016/s0009-8981(97)00051-x Open DOISearch in Google Scholar

40. Ellman GL. A colorimetric method for determining low concentrations of mercaptans. Arch Biochem Biophys 1958;74:443–50. doi: 10.1016/0003-9861(58)90014-6 Ellman GL . A colorimetric method for determining low concentrations of mercaptans . Arch Biochem Biophys 1958 ; 74 : 443 – 50 . doi: 10.1016/0003-9861(58)90014-6 Open DOISearch in Google Scholar

41. Rowe P. Essential Statistics for the Pharmaceutical Sciences. Chichester: Wiley; 2007. ISBN: 9780470034682 Rowe P . Essential Statistics for the Pharmaceutical Sciences . Chichester : Wiley ; 2007 . ISBN: 9780470034682 Search in Google Scholar

42. Bełtowski J, Wójcicka G, Mydlarczyk M, Jamroz A. Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat. Pol J Pharmacol 2002;54:143–50. PMID: 12139111 Bełtowski J Wójcicka G Mydlarczyk M Jamroz A . Cerivastatin modulates plasma paraoxonase/arylesterase activity and oxidant-antioxidant balance in the rat . Pol J Pharmacol 2002 ; 54 : 143 – 50 . PMID: 12139111 Search in Google Scholar

43. Liang H, Feng Y, Cui R, Qiu M, Zhang J, Liu C. Simvastatin protects against acetaminophen-induced liver injury in mice. Biomed Pharmacother 2018;98:916–24. doi: 10.1016/j.biopha. 2017.12076 Liang H Feng Y Cui R Qiu M Zhang J Liu C . Simvastatin protects against acetaminophen-induced liver injury in mice . Biomed Pharmacother 2018 ; 98 : 916 – 24 . doi: 10.1016/j.biopha. 2017.12076 Open DOISearch in Google Scholar

44. Zhang F, Sun D, Chen J, Guan N, Huo X, Xi H. Simvastatin attenuates angiotensin II-induced inflammation and oxidative stress in human mesangial cells. Mol Med Rep 2015;11:1246–51. doi: 10.3892/mmr.2014-2871 Zhang F Sun D Chen J Guan N Huo X Xi H . Simvastatin attenuates angiotensin II-induced inflammation and oxidative stress in human mesangial cells . Mol Med Rep 2015 ; 11 : 1246 – 51 . doi: 10.3892/mmr.2014-2871 Open DOISearch in Google Scholar

45. Zinellu A, Mangoni AA. A systematic review and meta-analysis of the effect of statins on glutathione peroxidase, superoxide dismutase, and catalase. Antioxidants (Basel) 2021;10(11):1841. doi: 10.3390/antiox10111841 Zinellu A Mangoni AA . A systematic review and meta-analysis of the effect of statins on glutathione peroxidase, superoxide dismutase, and catalase . Antioxidants (Basel) 2021 ; 10 ( 11 ): 1841 . doi: 10.3390/antiox10111841 Open DOISearch in Google Scholar

46. Verma K, Makwana S, Paliwal S, Paliwal V, Jain S, Paliwal S, Sharma S. Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidaemic rats. Curr Res Pharmacol Drug Discov 2022;3:100088. doi: 10.1016/j.crphar.2022.100088 Verma K Makwana S Paliwal S Paliwal V Jain S Paliwal S Sharma S . Simvastatin ameliorates oxidative stress levels in HepG2 cells and hyperlipidaemic rats . Curr Res Pharmacol Drug Discov 2022 ; 3 : 100088 . doi: 10.1016/j.crphar.2022.100088 Open DOISearch in Google Scholar

47. Wahba MGF, Messiha BAS, Abo-Saif AA. Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats. Pharm Biol 2016;54:1705–15. doi: 10.3109/13880209. 2015.1125931 Wahba MGF Messiha BAS Abo-Saif AA . Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats . Pharm Biol 2016 ; 54 : 1705 – 15 . doi: 10.3109/13880209. 2015.1125931 Open DOISearch in Google Scholar

48. Aberg F, Appelkvist EL. Clofibrate and di(2-ethylhexyl) phthalate increase ubiquinone contents without affecting cholesterol levels. Acta Biochim Pol 1994;41:321–9. PMID: 7856403 Aberg F Appelkvist EL . Clofibrate and di(2-ethylhexyl) phthalate increase ubiquinone contents without affecting cholesterol levels . Acta Biochim Pol 1994 ; 41 : 321 – 9 . PMID: 7856403 Search in Google Scholar

49. Arnaiz LS, Travacio M, Monserrat AJ, Cutrín JC, Llesuy S, Boveris A. Chemiluminescence and antioxidant levels during peroxisome proliferation by fenofibrate. Biochim Biophys Acta 1997;1360:222–8. doi: 10.1016/s0925-4439(97)00004-5 Arnaiz LS Travacio M Monserrat AJ Cutrín JC Llesuy S Boveris A . Chemiluminescence and antioxidant levels during peroxisome proliferation by fenofibrate . Biochim Biophys Acta 1997 ; 1360 : 222 – 8 . doi: 10.1016/s0925-4439(97)00004-5 Open DOISearch in Google Scholar

50. Tkác I, Molcányiová A, Javorský M, Kozárová M. Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity. Pharmacol Res 2006;53:261–4. doi: 10.1016/j.phrs.2005.12.002 Tkác I Molcányiová A Javorský M Kozárová M . Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity . Pharmacol Res 2006 ; 53 : 261 – 4 . doi: 10.1016/j.phrs.2005.12.002 Open DOISearch in Google Scholar

51. Jiao H-L, Zhao B-L. Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms. Toxicol Appl Pharmacol 2002;185:172–9. doi: 10.1006/taap.2002.9538 Jiao H-L Zhao B-L . Cytotoxic effect of peroxisome proliferator fenofibrate on human HepG2 hepatoma cell line and relevant mechanisms . Toxicol Appl Pharmacol 2002 ; 185 : 172 – 9 . doi: 10.1006/taap.2002.9538 Open DOISearch in Google Scholar

52. Shore LJ, Fenselau C, King AR, Dickinson RG. Characterization and formation of the glutathione conjugate of clofibric acid. Drug Metab Dispos 1995;23:119–23. PMID: 7720514 Shore LJ Fenselau C King AR Dickinson RG . Characterization and formation of the glutathione conjugate of clofibric acid . Drug Metab Dispos 1995 ; 23 : 119 – 23 . PMID: 7720514 Search in Google Scholar

53. Sun B, Xie Y, Jiang J, Wang Y, Xu X, Zhao C, Huang F. Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia. Lipids Health Dis 2015;14:27. doi: 10.1186/s12944-015-0032-3 Sun B Xie Y Jiang J Wang Y Xu X Zhao C Huang F . Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia . Lipids Health Dis 2015 ; 14 : 27 . doi: 10.1186/s12944-015-0032-3 Open DOISearch in Google Scholar